In contrast, plasma concentrations of the DC growth factor GM-CSF were similar in CAD patients and controls and did not correlate with mDC or pDC counts [12], indicating that it is unlikely that GM-CSF accounts for the decreased numbers of blood DCs in human CAD. Here, CSF2 is linked to coronary artery disorder.